Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2010, Article ID 456841, 8 pages
http://dx.doi.org/10.1155/2010/456841
Review Article

Apoptotic Pathways in Pemphigus

1Department of Dermatology, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
2Department of Pharmacology, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
3Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA

Received 14 December 2009; Accepted 24 February 2010

Academic Editor: Mỹ G. Mahoney

Copyright © 2010 Meryem Bektas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Eyre and J. R. Stanley, “Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients,” Journal of Experimental Medicine, vol. 165, no. 6, pp. 1719–1724, 1987. View at Google Scholar · View at Scopus
  2. M. Amagai, V. Klaus-Kovtun, and J. R. Stanley, “Autoantibodies against a novel epithelial cadherin in Pemphigus vulgaris, a disease of cell adhesion,” Cell, vol. 67, no. 5, pp. 869–877, 1991. View at Google Scholar · View at Scopus
  3. X. Ding, V. Aoki, J. M. Mascaro, A. Lopez-Swiderski, L. A. Diaz, and J. A. Fairley, “Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles,” Journal of Investigative Dermatology, vol. 109, no. 4, pp. 592–596, 1997. View at Google Scholar · View at Scopus
  4. M. Amagai, K. Tsunoda, D. Zillikens, T. Nagai, and T. Nishikawa, “The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile,” Journal of the American Academy of Dermatology, vol. 40, no. 2, part 1, pp. 167–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Miyagawa, M. Amagai, T. Iida, Y. Yamamoto, T. Nishikawa, and T. Shirai, “Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression,” British Journal of Dermatology, vol. 141, no. 6, pp. 1084–1087, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. G. J. Anhalt, R. S. Labib, and J. J. Voorhees, “Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease,” The New England Journal of Medicine, vol. 306, no. 20, pp. 1189–1196, 1982. View at Google Scholar
  7. J. T. Roscoe, L. Diaz, and S. A. P. Sampaio, “Brazilian pemphogus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer,” Journal of Investigative Dermatology, vol. 85, no. 6, pp. 538–541, 1985. View at Google Scholar · View at Scopus
  8. M. Seishima, C. Esaki, K. Osada, S. Mori, T. Hashimoto, and Y. Kitajima, “Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-trisphosphate in DJM-1 cells, a squamous cell carcinoma line,” Journal of Investigative Dermatology, vol. 104, no. 1, pp. 33–37, 1995. View at Google Scholar · View at Scopus
  9. K. Osada, M. Seishima, and Y. Kitajima, “Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes,” Journal of Investigative Dermatology, vol. 108, no. 4, pp. 482–487, 1997. View at Google Scholar · View at Scopus
  10. M. Seishima, Y. Iwasaki-Bessho, Y. Itoh, Y. Nozawa, M. Amagai, and Y. Kitajima, “Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction,” Archives of Dermatological Research, vol. 291, no. 11, pp. 606–613, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Aoyama, M. K. Owada, and Y. Kitajima, “A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes,” European Journal of Immunology, vol. 29, no. 7, pp. 2233–2240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Waschke, V. Spindler, P. Bruggeman, D. Zillikens, G. Schmidt, and D. Drenckhahn, “Inhibition of Rho A activity causes pemphigus skin blistering,” Journal of Cell Biology, vol. 175, no. 5, pp. 721–727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Caldelari, A. De Bruin, D. Baumann et al., “A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris,” Journal of Cell Biology, vol. 153, no. 4, pp. 823–834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. C. C. Calkins, S. V. Setzer, J. M. Jennings et al., “Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies,” Journal of Biological Chemistry, vol. 281, no. 11, pp. 7623–7634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Delva, J. M. Jennings, C. C. Calkins, M. D. Kottke, V. Faundez, and A. P. Kowalczyk, “Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism,” Journal of Biological Chemistry, vol. 283, no. 26, pp. 18303–18313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. I. Chernyavsky, J. Arredondo, Y. Kitajima, M. Sato-Nagai, and S. A. Grando, “Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens,” Journal of Biological Chemistry, vol. 282, no. 18, pp. 13804–13812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Williamson, N. A. Raess, R. Caldelari et al., “Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin,” EMBO Journal, vol. 25, no. 14, pp. 3298–3309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Lanza, N. Cirillo, R. Rossiello et al., “Evidence of key role of Cdk2 overexpression in pemphigus vulgaris,” Journal of Biological Chemistry, vol. 283, no. 13, pp. 8736–8745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wang, F. Brégégère, M. Frušić-Zlotkin, M. Feinmesser, B. Michel, and Y. Milner, “Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins,” Apoptosis, vol. 9, no. 2, pp. 131–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Wolf, H. Matz, E. Ruocco, and V. Ruocco, “The putative role of apoptosis in the induction of pemphigus,” Medical Hypotheses, vol. 64, no. 1, pp. 44–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Zuccolotto, A. M. Roselino, L. N. Z. Ramalho, and S. Zucoloto, “Apoptosis and p63 expression in the pathogenesis of bullous lesions of endemic pemphigus foliaceus,” Archives of Dermatological Research, vol. 295, no. 7, pp. 284–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Puviani, A. Marconi, E. Cozzani, and C. Pincelli, “Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8,” Journal of Investigative Dermatology, vol. 120, no. 1, pp. 164–167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Chiarugi and E. Giannoni, “Anoikis: a necessary death program for anchorage-dependent cells,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1352–1364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. Schiltz, B. Michel, and R. Papay, “Pemphigus antibody interaction with human epidermal cells in culture,” Journal of Clinical Investigation, vol. 62, no. 4, pp. 778–788, 1978. View at Google Scholar · View at Scopus
  26. M. G. Pacheco-Tovar, E. Avalos-Díaz, E. Vega-Memije et al., “The final destiny of acantholytic cells in pemphigus is Fas mediated,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 6, pp. 697–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Sayama, S. Yonehara, Y. Watanabe, and Y. Miki, “Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes,” Journal of Investigative Dermatology, vol. 103, no. 3, pp. 330–334, 1994. View at Google Scholar · View at Scopus
  28. D. B. R. Rodrigues, S. A. L. Pereira, M. A. D. Reis et al., “In situ detection of inflammatory cytokines and apoptosis in pemphigus foliaceus patients,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 1, pp. 97–100, 2009. View at Google Scholar · View at Scopus
  29. K. Reich, U. Brinck, M. Letschert et al., “Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus,” British Journal of Dermatology, vol. 141, no. 4, pp. 739–746, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. K. F. Köhler and M. L. Petzl-Erler, “No evidence for association of the TP53 12139 and the BAX-248 polymorphisms with endemic pemphigus foliaceus (fogo selvagem),” International Journal of Immunogenetics, vol. 33, no. 2, pp. 141–144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Grando, J.-C. Bystryn, A. I. Chernyavsky et al., “Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis,” Experimental Dermatology, vol. 18, no. 9, pp. 764–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Weiske, T. Schöneberg, W. Schröder, M. Hatzfeld, R. Tauber, and O. Huber, “The fate of desmosomal proteins in apoptotic cells,” Journal of Biological Chemistry, vol. 276, no. 44, pp. 41175–41181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. R. L. Dusek, S. Getsios, F. Chen et al., “The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes,” Journal of Biological Chemistry, vol. 281, no. 6, pp. 3614–3624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Caulín, G. S. Salvesen, and R. G. Oshima, “Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis,” Journal of Cell Biology, vol. 138, no. 6, pp. 1379–1394, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. N.-O. Ku, J. Liao, and M. B. Omary, “Apoptosis generates stable fragments of human type I keratins,” Journal of Biological Chemistry, vol. 272, no. 52, pp. 33197–33203, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Wang, F. Brégégère, Y. Soroka, M. Frusic-Zlotkin, and Y. Milner, “Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes,” FEBS Letters, vol. 567, no. 2 –3, pp. 281–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Baroni, E. Buommino, I. Paoletti, M. Orlando, E. Ruocco, and V. Ruocco, “Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes,” British Journal of Dermatology, vol. 150, no. 6, pp. 1070–1080, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Li, M. Zhao, J. Wang, Z. Liu, and L. A. Diaz, “Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin,” Journal of Immunology, vol. 182, no. 1, pp. 711–717, 2009. View at Google Scholar · View at Scopus
  39. E. Schmidt, J. Gutberlet, D. Siegmund, D. Berg, H. Wajant, and J. Waschke, “Apoptosis is not required for acantholysis in pemphigus vulgaris,” American Journal of Physiology, vol. 296, no. 1, pp. C162–C172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Berkowitz, P. Hu, Z. Liu et al., “Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization,” Journal of Biological Chemistry, vol. 280, no. 25, pp. 23778–23784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Berkowitz, P. Hu, S. Warren, Z. Liu, L. A. Diaz, and D. S. Rubenstein, “p38MAPK inhibition prevents disease in pemphigus vulgaris mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 34, pp. 12855–12860, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Berkowitz, M. Chua, Z. Liu, L. A. Diaz, and D. S. Rubenstein, “Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin,” American Journal of Pathology, vol. 173, no. 6, pp. 1628–1636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Kawasaki, Y. Aoyama, K. Tsunoda, M. Amagai, and Y. Kitajima, “Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line,” Autoimmunity, vol. 39, no. 7, pp. 587–590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J. N. Lavoie, E. Hickey, L. A. Weber, and J. Landry, “Modulation of actin-microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27,” Journal of Biological Chemistry, vol. 268, no. 32, pp. 24210–24214, 1993. View at Google Scholar · View at Scopus
  45. J. N. Lavoie, H. Lambert, E. Hickey, L. A. Weber, and J. Landry, “Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27,” Molecular & Cellular Biology, vol. 15, no. 1, pp. 505–516, 1995. View at Google Scholar · View at Scopus
  46. J. Guay, H. Lambert, G. Gingras-Breton, J. N. Lavoie, J. Huot, and J. Landry, “Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27,” Journal of Cell Science, vol. 110, no. 3, pp. 357–368, 1997. View at Google Scholar · View at Scopus
  47. M. D. der Perng, L. Cairns, P. Van Den IJssel, A. Prescott, A. M. Hutcheson, and R. A. Quinlan, “Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin,” Journal of Cell Science, vol. 112, no. 13, pp. 2099–2112, 1999. View at Google Scholar · View at Scopus
  48. L. Feng, X. Zhou, J. Liao, and M. B. Omary, “Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway,” Journal of Cell Science, vol. 112, no. 13, pp. 2081–2090, 1999. View at Google Scholar · View at Scopus
  49. O. V. Evgrafov, I. Mersiyanova, J. Irobi et al., “Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy,” Nature Genetics, vol. 36, no. 6, pp. 602–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. S. R. Woll, R. Windoffer, and R. E. Leube, “p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells,” Journal of Cell Biology, vol. 177, no. 5, pp. 795–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. S. Jolly, P. Berkowitz, M. Bektas et al., “p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis,” Journal of Biological Chemistry, vol. 285, pp. 8936–8941, 2010. View at Publisher · View at Google Scholar
  52. Z. Xia, M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg, “Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis,” Science, vol. 270, no. 5240, pp. 1326–1331, 1995. View at Google Scholar · View at Scopus
  53. P. Juo, C. J. Kuo, S. E. Reynolds et al., “Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family protease,” Molecular and Cellular Biology, vol. 17, no. 1, pp. 24–35, 1997. View at Google Scholar · View at Scopus
  54. P. A. Henkart, “Ice family proteases: mediators of all apoptotic cell death?” Immunity, vol. 4, no. 3, pp. 195–201, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. H. E. Lee, P. Berkowitz, P. S. Jolly, L. A. Diaz, M. P. Chua, and D. S. Rubenstein, “Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis,” Journal of Biological Chemistry, vol. 284, no. 18, pp. 12524–12532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. G.-Z. Tao, K. S. Looi, D. M. Toivola et al., “Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis,” Journal of Cell Science, vol. 122, no. 21, pp. 3851–3855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Schwerk and K. Schulze-Osthoff, “Non-apoptotic functions of caspases in cellular proliferation and differentiation,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1453–1458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Futamura, C. Martins, E. A. Rivitti, R. S. Labib, L. A. Diaz, and G. J. Anhalt, “Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (fogo selvagem),” Journal of Investigative Dermatology, vol. 93, no. 4, pp. 480–485, 1989. View at Google Scholar · View at Scopus
  59. Y. Aoyama and Y. Kitajima, “Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3- depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells,” Journal of Investigative Dermatology, vol. 112, no. 1, pp. 67–71, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Cirillo, F. Gombos, and A. Lanza, “Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity,” Journal of Cellular Physiology, vol. 210, no. 2, pp. 411–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Mao, E. J. Choi, and A. S. Payne, “Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies,” Journal of Investigative Dermatology, vol. 129, no. 4, pp. 908–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Amagai, N. Matsuyoshi, Z. H. Wang, C. Andl, and J. R. Stanley, “Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1,” Nature Medicine, vol. 6, no. 11, pp. 1275–1277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Hanakawa, N. M. Schechter, C. Lin et al., “Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome,” Journal of Clinical Investigation, vol. 110, no. 1, pp. 53–60, 2002. View at Publisher · View at Google Scholar · View at Scopus